The U.S. Senate has passed spending package for lupus-specific research.
Upcoming Events See all events >
No upcoming events.
Latest News See all stories >
CEO Sandra C. Raymond responds to announcement of Phase III trial results of anifrolumab.
Exagen Diagnostics and CareFirst BlueCross have come together for the new lupus diagnostic test.
Grant awardees focus on moving research forward in two critical areas, childhood lupus and kidney damage
Find a trial that matches your needs and interests in 60 seconds.